Skip to main content
PMC home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2008 Sep;4(3):184–191. doi: 10.1007/BF03161199

Intravenous lipid emulsion for local anesthetic toxicity: A review of the literature

Kristen L Felice 1, Heather M Schumann 1,✉
PMCID: PMC3550038  PMID: 18821493

Abstract

Introduction

The use of intravenous lipid emulsion (IVLE) has been proposed as a new potential treatment for local anesthetic toxicity. Local anesthetics work through reversible binding at sodium channels, and signs and symptoms of toxicity include central nervous system and cardiovascular effects. Cardiovascular collapse is a potential result of local anesthetic toxicity, and is generally resistant to resuscitation efforts with standard measures.

Discussion

Various animal studies have been published investigating the use of IVLE in local anesthetic toxicity. IVLE has been shown to increase the lethal dose of bupivacaine required, resuscitate animals that underwent local anesthetic-induced cardiovascular collapse, and more quickly reduce the amount of local anesthetic in the myocardium (compared to administration of control solution). Four human case reports utilizing IVLE for presumed local anesthetic toxicity, with varying presentations, are reviewed.

Conclusions

IVLE has shown to be an interesting prospect for local anesthetic toxicity. Human case reports have shown successful resuscitation with use of IVLE, using varying dosing regimens. More studies are needed to determine the optimal dosing regimen, as well as to determine the potential adverse effects of IVLE when used in this setting.

Keywords: Lipid emulsion, local anesthetic, toxicity

Full Text

The Full Text of this article is available as a PDF (127.2 KB).

Footnotes

There was no outside funding of any kind used for this study.

References

  • 1.Faccenda KA, Finucane BT. Complications of regional anaesthesia: incidence and prevention. Drug Safety. 2001;24(6):413–442. doi: 10.2165/00002018-200124060-00002. [DOI] [PubMed] [Google Scholar]
  • 2.Heavner JE. Local anesthetics. Curr Opin Anaesthesiol. 2007;20:336–342. doi: 10.1097/ACO.0b013e3281c10a08. [DOI] [PubMed] [Google Scholar]
  • 3.Jackson T, McLure HA. Pharmacology of local anesthetics. Ophthalmol Clin North Am. 2006;19:155–161. doi: 10.1016/j.ohc.2006.02.006. [DOI] [PubMed] [Google Scholar]
  • 4.Schwartz DR, Kaufman B. Local anesthetics. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, editors. Goldfrank’s Toxicologic Emergencies. 8th ed. New York: McGraw-Hill; 2006. pp. 1004–1015. [Google Scholar]
  • 5.Cox B, Durieux ME, Marcus MAE. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):111–136. doi: 10.1053/bean.2003.0275. [DOI] [PubMed] [Google Scholar]
  • 6.Picard J, Meek T. Lipid emulsion to treat overdose of local anaesthetic: the gift of the glob. Anaesthesia. 2006;61:107–109. doi: 10.1111/j.1365-2044.2005.04494.x. [DOI] [PubMed] [Google Scholar]
  • 7.Strichartz GR, Berde CB. Local anesthetics. In: Miller RD, editor. Miller’s Anesthesia. 6th ed. Philadelphia: Elsevier, Inc.; 2005. pp. 573–603. [Google Scholar]
  • 8.McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005;71:59–74. [PubMed] [Google Scholar]
  • 9.Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med. 2002;27:556–561. doi: 10.1053/rapm.2002.37127. [DOI] [PubMed] [Google Scholar]
  • 10.Weinberg G. Lipid rescue resuscitation from local anaesthetic cardiac toxicity. Toxicol Rev. 2006;25(3):139–145. doi: 10.2165/00139709-200625030-00001. [DOI] [PubMed] [Google Scholar]
  • 11.Beilin Y, Bodian CA, Haddad EM, Leibowitz AB. Practice patterns of anesthesiologists regarding situations in obstetric anesthesia where clinical management is controversial. Anesth Analg. 1996;83:735–741. doi: 10.1097/00000539-199610000-00013. [DOI] [PubMed] [Google Scholar]
  • 12.Lidocaine hydrochloride. In: McEvoy GK, editor. AHFS drug information 2007. Bethesda, MD: American Society of Health-System Pharmacists, Inc.; 2007. p. 1599–1602.
  • 13.Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med. 2005;30:553–566. doi: 10.1016/j.rapm.2005.07.186. [DOI] [PubMed] [Google Scholar]
  • 14.Weinberg GL, Massad MG. Metabolic modulation for cardiac protection. Expert Rev Cardiovasc Ther. 2007;5(2):135–138. doi: 10.1586/14779072.5.2.135. [DOI] [PubMed] [Google Scholar]
  • 15.Intralipid® 20% (a 20% I.V. fat emulsion in Excel® container) [package insert]. Deerfield, IL: Baxter Healthcare Corporation; 2006.
  • 16.Olivecrona G, Olivecrona T. Clearance of artificial tri-acylglycerol particles. Curr Opin Clin Nutr Metab Care. 1998;1:143–151. doi: 10.1097/00075197-199803000-00002. [DOI] [PubMed] [Google Scholar]
  • 17.Weinberg GL, Ripper R, Murphy P, et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. RegAnesth Pain Med. 2006;31:296–303. doi: 10.1016/j.rapm.2005.02.011. [DOI] [PubMed] [Google Scholar]
  • 18.Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion reduces dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198–202. doi: 10.1053/rapm.2003.50041. [DOI] [PubMed] [Google Scholar]
  • 19.Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA. 1992;89:6452–6456. doi: 10.1073/pnas.89.14.6452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ordway RW, Walsh JV, Singer JJ. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science. 1989;244:1176–1179. doi: 10.1126/science.2471269. [DOI] [PubMed] [Google Scholar]
  • 21.Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88(4):1071–1075. doi: 10.1097/00000542-199804000-00028. [DOI] [PubMed] [Google Scholar]
  • 22.Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217–218. doi: 10.1097/00000542-200607000-00033. [DOI] [PubMed] [Google Scholar]
  • 23.Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia. 2006;61:800–801. doi: 10.1111/j.1365-2044.2006.04740.x. [DOI] [PubMed] [Google Scholar]
  • 24.Foxall G, McCahon R, Lamb J, Hardman JG, Bedforth NM. Levobupivacaine-induced seizures and cardiovascular collapse treated with Intralipid®. Anaesthesia. 2007;62:516–518. doi: 10.1111/j.1365-2044.2007.05065.x. [DOI] [PubMed] [Google Scholar]
  • 25.Spence AG. Lipid reversal of central nervous system symptoms of bupivacaine toxicity. Anesthesiology. 2007;107:516–517. doi: 10.1097/01.anes.0000278864.75082.72. [DOI] [PubMed] [Google Scholar]
  • 26.LipidRescue™ resuscitation for cardiac toxicity: treatment regimens [webpage on the Internet]. Treatment regimens. Weinberg G [cited 29 Aug 2007]. Available from:http://www.lipidrescue.org
  • 27.Bania TC, Chu J, Perez E, Su M, Hahn IH. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med. 2007;14:105–111. doi: 10.1111/j.1553-2712.2007.tb01752.x. [DOI] [PubMed] [Google Scholar]
  • 28.Kasi VS, Estrada CA, Wiese W. Association of pancreatitis with administration of contrast medium and intravenous lipid emulsion in a patient with the acquired immunodeficiency syndrome. South Med J. 2003;96:66–69. doi: 10.1097/01.SMJ.0000047667.00302.CD. [DOI] [PubMed] [Google Scholar]
  • 29.Han J, Davis SS, Washington C. Physical properties and stability of two emulsion formulations of propofol. Int J Pharm. 2001;215:207–220. doi: 10.1016/S0378-5173(00)00692-X. [DOI] [PubMed] [Google Scholar]
  • 30.Weinberg G, Hertz P, Newman J. Lipid, not propofol, treats bupivacaine overdose. Anesth Analg. 2004;99:1871–1882. doi: 10.1213/01.ANE.0000138550.57760.22. [DOI] [PubMed] [Google Scholar]
  • 31.Shupak RC. Lipid emulsion for bupivacaine toxicity: too soon to celebrate? Anesthesiology. 2007;106:634–635. doi: 10.1097/00000542-200703000-00034. [DOI] [PubMed] [Google Scholar]
  • 32.Sirianni AJ, Osterhoudt KC, Calello DP, Mueller AA, Waterhouse MR, Goodkin MB, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51:412–415. doi: 10.1016/j.annemergmed.2007.06.004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES